Cargando...
How I treat refractory chronic graft-versus-host disease
Approximately 35% to 50% of patients otherwise cured of hematologic malignancies after allogeneic hematopoietic stem cell transplantation will develop the pleomorphic autoimmune-like syndrome known as chronic graft-versus-host disease (cGVHD). Since in 2005, National Institutes of Health (NIH) conse...
Gardado en:
| Publicado en: | Blood |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Hematology
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6418480/ https://ncbi.nlm.nih.gov/pubmed/30674472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-04-785899 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|